Literature DB >> 16026580

Ex vivo analysis of desmoglein 1-responsive T-helper (Th) 1 and Th2 cells in patients with pemphigus foliaceus and healthy individuals.

Kerstin L Gebhard1, Christian M Veldman, Ralf Wassmuth, Erwin Schultz, Gerold Schuler, Michael Hertl.   

Abstract

Pemphigus foliaceus (PF) is a severe autoimmune bullous disorder, characterized by autoantibodies (autoAb) against desmoglein 1 (Dsg1). As T cells may be critical in the pathology of PF, the aim of the present study was to identify and characterize autoaggressive T-helper cells reactive to Dsg1 in PF patients and healthy individuals. Eight patients with the clinical diagnosis of PF and six HLA class II-matched healthy individuals were examined. By magnetic cell-sorting (MACS) cytokine-secretion assay, Dsg1-responsive T-helper (Th) 1 and Th2 cells were isolated and cloned by limiting dilution. The generated T-cell clones (TCC) were characterized regarding proliferative response, TCR Vbeta-chain usage, and cytokine profile upon in vitro stimulation with Dsg1. Both Dsg1-reactive Th1 and Th2 cells were detected in PF patients and controls at similar frequencies. A total of 15 Th1 and Th2 clones were isolated from patients and 27 TCC from healthy controls. Analysis of TCR Vbeta-chain usage of autoreactive T cells from both groups revealed no predominance of a specific Vbeta chain. Noteworthy, the isolated TCC showed a polarized Th1- or Th2-like phenotype upon in vitro culture and stable expression of Th1 or Th2 cytokines during long-term in vitro culture. In summary, our data demonstrate that T-cell autoreactivity against Dsg1 is not restricted to patients with PF. Moreover, both Th1 and Th2 cells were present in patients and healthy donors, suggesting that the loss of B-cell tolerance against Dsg1 in PF is not exclusively determined by the presence of autoaggressive T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026580     DOI: 10.1111/j.0906-6705.2005.00329.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

Review 1.  T cell control in autoimmune bullous skin disorders.

Authors:  Michael Hertl; Rüdiger Eming; Christian Veldman
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 2.  A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris.

Authors:  Vincent Van Drongelen; Joseph Holoshitz
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

Review 3.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

4.  The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.

Authors:  Ruth Fritsch-Stork; Daniela Müllegger; Karl Skriner; Beatrice Jahn-Schmid; Josef S Smolen; Günter Steiner
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

5.  Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous.

Authors:  Alberta Lucchese; Abraham Mittelman; Luciana Tessitore; Rosario Serpico; Animesh A Sinha; Darja Kanduc
Journal:  J Transl Med       Date:  2006-08-22       Impact factor: 5.531

6.  Involvement of the IL23/Th17 Pathway in the Pathogenesis of Tunisian Pemphigus Foliaceus.

Authors:  M Ben Jmaa; O Abida; R Fakhfakh; E Bahloul; Kh Sellami; L Gaddour; N Elloumi; M Ben Ayed; A Masmoudi; M Dhouib; M Abdelmoula; N Mahfoudh; H Makni; H Turki; H Masmoudi
Journal:  Mediators Inflamm       Date:  2018-07-12       Impact factor: 4.711

Review 7.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Authors:  Inga Koneczny; Vuslat Yilmaz; Konstantinos Lazaridis; John Tzartos; Tobias L Lenz; Socrates Tzartos; Erdem Tüzün; Frank Leypoldt
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.